Results 141 to 150 of about 128,502 (303)

International Contrast Ultrasound Society Safety Round Table

Journal of Ultrasound in Medicine, EarlyView.
The international Contract Ultrasound Society (ICUS) held a round table discussion on the safety of ultrasound contrast agents for cardiology, radiology, and pediatrics on September 4, 2024. The panel included international experts on ultrasound contrast.
Richard G. Barr, Jordan Strom, Dirk A. Clevert, Stephanie R Wilson, Thomas Porter, Kassa Darge   +5 more
wiley   +1 more source

Evaluating ECG Criteria for Diagnosing Left Ventricular Hypertrophy in Anabolic-Androgenic Steroid Users. [PDF]

JACC Adv
Abdullah R, Bjørnebekk A, Hauger LE, Hullstein IR, Edvardsen T, Haugaa K, Almaas VM.   +6 more
europepmc   +1 more source

Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus

, 2015
Elsayed Z. Soliman, Robert P. Byington, J. Thomas Bigger, Gregory W. Evans, Peter M. Okin, David C. Goff, Haiying Chen   +6 more
openalex   +1 more source

Fetal Ductal Constriction, Pulmonary Hypertension and Atrial Septum Mobility

Journal of Ultrasound in Medicine, EarlyView.
Objectives Fetuses with ductal constriction (FDC), pulmonary hypertension and right ventricular overload after maternal exposure to PGE2 inhibitors—nonsteroidal anti‐inflammatory drugs (NSAIDs) or polyphenols (PF)—have increased septum primum excursion index (SPEI), the ratio between maximal septum primum displacement and left atrial diameter.
Paulo Zielinsky, Polyanna Henriques, Pedro Van Der Sand, Maria Antonia Saldanha, Gabriela Macelaro, Joana Nicoloso   +5 more
wiley   +1 more source

Left Ventricular Hypertrophy [PDF]

, 2020
openaire   +1 more source

Nocturnal hypertension predicts left ventricular hypertrophy in children with primary hypertension. [PDF]

Transl Pediatr
Wang J, Zhang J, Chu C, Wang J, Liu F, Wang F, Gui Y.   +6 more
europepmc   +1 more source

Relationship Between Circulating MicroRNAs and Left Ventricular Hypertrophy in Hypertensive Patients

, 2022
Elisangela C. P. Lopes, Layde R. Paim, Luís F. R. S. Carvalho-Romano, Edmilson R. Marques, Eduarda O. Z. Minin, Camila Fernanda Lourençon Vegian, José A. Pio-Magalhães, Lı́cio A. Velloso, Otávio R. Coelho‐Filho, Andrei C. Spósito, José R. Matos‐Souza, Wilson Nadruz, Roberto Schreiber   +12 more
openalex   +1 more source

MiR‐145‐5p Attenuates Doxorubicin‐Induced Heart Injury Through Targeting Cardiomyocyte Pyroptosis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Doxorubicin (DOX), a potent anthracycline chemotherapeutic, exhibits dose‐dependent cardiotoxicity that limits its clinical utility. Although miR‐145‐5p demonstrates cardioprotective properties in cardiovascular diseases, its role in DOX‐induced cardiomyopathy remains undefined.
Xing‐Tao Chen, Yong‐Hong Yu, Yan‐Hua Du, Lin Xu, Xiang‐Ping Meng   +4 more
wiley   +1 more source

Cardiac magnetic resonance characteristics and prognostic associations of hypertension-mediated left ventricular hypertrophy. [PDF]

Eur Heart J Imaging Methods Pract
Naderi H, van Duijvenboden S, Ramírez J, Chadalavada S, Rauseo E, Aung N, Petersen SE, Munroe PB.   +7 more
europepmc   +1 more source

Sacubitril/Valsartan Ameliorates Inflammation and Oxidative Stress in Hypertensive Heart Disease by Upregulating CAMKK2 Protein and Modulating the AMPK/AKT/GSK‐3β Axis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Sacubitril/valsartan (Sac/Val) has emerged as an effective compound with myocardium‐protective functions in experimental and clinical trials for heart failure. This study investigated the function of Sac/Val in hypertensive heart disease (HHD) and explored the underlying mechanism.
Yan‐Jun Yang, Jiu‐Sheng Li
wiley   +1 more source